Mediastinal Diseases: Clinical Trials

8 trials for Mediastinal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 2 recruiting, 1 completed, 1 not yet recruiting. 8 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Terminated 3, Recruiting 2, Completed 1, Not yet recruiting 1, Unknown 1
Phase 32Not yet recruiting 1, Terminated 1

Follow Mediastinal Diseases: new trials by email Literature Review of Mediastinal Diseases trials Research Report on Mediastinal Diseases

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Atorvastatin and Lisinopril, Placebo - Chest Wall Tumor, Breast Cancer
Phase 2RecruitingUNC Lineberger Comprehensive Cancer Center602026-08-122026-09-17
6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors
Cyclophosphamide, Doxorubicin, and Cisplatin (CAP), nab-Paclitaxel and Carboplatin - Thymoma and Thymic Carcinoma
Phase 2 / Phase 3Not yet recruitingShanghai General Hospital, Shanghai Jiao Tong University School of Medicine1162026-03-012026-03-11
Phase II Trial of Lung Chemoemobolization
Computed Tomography, Ethiodized Oil, Mitomycin - Lung Non-Small Cell Carcinoma, Mediastinal Neoplasm
Phase 2RecruitingCity of Hope Medical Center302023-05-122026-03-05
MR-linac Guided Adaptive Radiotherapy for Inoperable Mediastinal Tumor
Unity-based MR-Linac guided Radiotherapy - Mediastinal Tumor
Phase 2UnknownSun Yat-sen University592021-10-012021-12-20
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Pembrolizumab - Germ Cell Neoplasms, Testicular Neoplasms
Phase 2TerminatedNasser Hanna, M.D.122016-01-012022-07-11
Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage
Belinostat (PDX101) - Thymoma, Thymic Carcinoma
Phase 2CompletedNational Cancer Institute (NCI)412007-12-012015-09-30
Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)
V710, Placebo - Staphylococcus Aureus, Bacteremia
Phase 2 / Phase 3TerminatedMerck Sharp & Dohme LLC80312007-12-012015-10-02
Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer
Intravenous Topotecan, Intravenous Docetaxel - Mediastinal Neoplasms
Phase 2TerminatedAultman Health Foundation72004-11-012018-08-20

Narrower conditions

Mediastinal Neoplasms (7)  ·  Thymoma (2)  ·  Bacteremia (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Cardiovascular Diseases (1)  ·  Colonic Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Genital Neoplasms, Female (1)  ·  Genital Neoplasms, Male (1)  ·  Lung Neoplasms (1)  ·  Mediastinitis (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Nonseminomatous germ cell tumor (1)  ·  Ovarian Neoplasms (1)

Broader conditions

Respiratory Tract Diseases (8)  ·  Thoracic Diseases (8)  ·  Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Thoracic Neoplasms (6)  ·  Neoplasms by Histologic Type (4)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Lung Diseases (2)  ·  Lymphatic Diseases (2)  ·  Neoplasms, Complex and Mixed (2)

Interventions

130-nm albumin-bound paclitaxel (1)  ·  Atorvastatin (1)  ·  Carboplatin (1)  ·  Cisplatin (1)  ·  Cyclophosphamide (1)  ·  Docetaxel (1)  ·  Doxorubicin (1)  ·  Ethiodized Oil (1)  ·  Iodized Oil (1)  ·  Lisinopril (1)  ·  Mitomycin (1)  ·  Mitozytrex (1)  ·  Topotecan (1)  ·  V710 vaccine (1)  ·  belinostat (1)

Sponsors

Aultman Health Foundation (1)  ·  City of Hope Medical Center (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Nasser Hanna, M.D. (1)  ·  National Cancer Institute (NCI) (1)  ·  Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)  ·  Sun Yat-sen University (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)

Countries

United States (5)  ·  China (2)

Top investigators

Fan Jiang, MD, PhD (1)  ·  Franz E Boas, MD (1)  ·  Giuseppe Giaccone, M.D. (1)  ·  Hui Liu (1)  ·  Nasser Hanna, M.D. (1)  ·  Raza Khan, MD (1)  ·  Shivani Sud, MD (1)

Results publications

PMID 21502553, PMID 23549582, PMID 29045540, PMID 37611799

NIH funding

P30CA033572 (1)